Search PubMed⌕ Search

Biomedical subjects

J D Ringe

Publications and source records attributed to J D Ringe.

128 records · Page 8Linked to original sources

[Generalized osteoporosis in chronic polyarthritis--pathomechanisms and treatment approaches].

Juxtaarticular osteoporosis is a typical x-ray symptom of rheumatoid arthritis and is an early radiological criterion of the disease before destructive changes of joints can be seen. A systemic osteoporosis, independent from corticoid treatment, will develop significantly later. Nevertheless both conditions have some pathogenetic mechanisms in common. The risk of generalized osteoporosis in rheumatoid arthritis correlates with the degree of inflammatory activity. Different cytokines originating from the affected joints can be measured in plasma at increased levels and augment osteoclastic activity in bone tissue. During the early phase of disease the best prevention of osteoporosis is therefore adequate suppression of inflammation. Taking into account these mechanisms, corticoid treatment may be osteoprotective. Clinical manifestation of systemic osteoporosis in rheumatic patients depends on bone mass at onset of disease, on the activity of inflammation, and on additional negative effects on bone mass due to corticoids and immobility.

Adrenal Cortex Hormones↗

[Guidelines for improved therapeutic strategy in patients with Paget's osteitis deformans].

Paget's disease is a localized mono- or polyostotic progressive bone disease of possibly viral etiology characterized by increased bone remodeling, leading to pain, fractures, and skeletal deformities with the risk of osseous, articular and neurological complications. Appropriate treatment should be given to any patient with symptoms and any patient with a pagetic lesion in a high risk location, even if the patient is asymptomatic. First choice of treatment are now potent new bisphosphonates of second generation. These substances are captured in pagetic bone at high concentrations giving a continuing therapeutic effect after application has ceased. Monitoring the course of biochemical markers of bone turnover allows individual decisions about duration and frequency of treatment courses.

Diphosphonates↗